More than 60 Congressional representatives from both sides of the aisle have called on House appropriators to significantly increase federal resources in the year ahead to tackle the growing crisis of infections that do not respond to available treatments.
Despite the critical role ID physicians play in combating some of the most critical public health crises of our time, the ID profession continues to be under-valued. While ID physician compensation data is clear, there is a data gap on comprehensive documentation of how hard ID physicians are working, and how you are spending your time. The data collected from the survey will be used by IDSA to develop educational and negotiation tools that you can use later this year. Take the survey today!
The Biden Administration’s pledge of medical aid for India to combat the country’s surge of COVID-19 shows an important commitment to tackling the pandemic as a shared crisis. We commend the Administration for taking this step and for its plans to share up to 60 million doses of the AstraZeneca vaccine.
Updated recommendations on the use of COVID-19 convalescent plasma, neutralizing antibodies and remarks on remdesivir now available in IDSA's COVID-19 Treatment and Management Guideline.
“Today’s announcement by FDA and CDC to temporarily pause the administration of the Johnson & Johnson COVID-19 vaccine is an indication that our safety monitoring system is working." Read More.